Gland Pharma Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹118(7.87%)
Premium (ELP)
Having completed its public offering, Gland Pharma Limited's is now listed and trading on the NSE, BSE exchange as of Nov 20, 2020. The IPO raised cumulative capital of 4,31,96,968 Shares, including 83,33,333 Shares in primary capital infusion and ₹5229.55 Cr in secondary market transactions.
The IPO was conducted with a price range of ₹1,490 to ₹1,500 and minimum investment requirement of 10 shares. subscription activity between Nov 09, 2020 and Nov 11, 2020 reflected market assessment of the offering's valuation and prospects.
The allotment process finalized on Nov 18, 2020 distributed equity ownership to successful bidders. The listing established a transparent market mechanism for share trading, price discovery, and investor participation in the company's future growth.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Wide range of complex injectable products.
- Diversified B2B model with a growing B2C presence in India.
- Advanced and scalable manufacturing capabilities.
- Strong financial performance and consistent growth.
- Led by an experienced and skilled management team.
NA
- Fosun Pharma Industrial Pte. Ltd
- Shanghai Fosun Pharmaceutical (Group) Co. Ltd
Gland Pharma Limited
Link Intime India Private Limited